Avasa Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.81M
- Investors
-
11
Avasa General Information
Description
Developer of medical devices designed for reconstructive surgery. The company offers a proprietary device that standardizes vascular eversion to connect both arteries and veins in reconstructive microsurgery, enabling surgeons to reduce transplant failures and readmissions.
Contact Information
Website
www.avasa.ioCorporate Office
- 70 Symonds Street
- Grafton
- Auckland, 1010
- New Zealand
Corporate Office
- 70 Symonds Street
- Grafton
- Auckland, 1010
- New Zealand
Avasa Timeline
Avasa Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 26-Aug-2025 | $2.81M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 19-Sep-2023 | Completed | Generating Revenue | |||
| 2. Angel (individual) | 01-Jul-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Jan-2022 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Avasa Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Avasa Patents
Avasa Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4054437-A1 | A tubular tissue transformer | Pending | 08-Nov-2019 | ||
| EP-4054437-A4 | A tubular tissue transformer | Pending | 08-Nov-2019 | ||
| US-20220378430-A1 | A tubular tissue transformer | Pending | 08-Nov-2019 | ||
| WO-2021091398-A1 | A tubular tissue transformer | Inactive | 08-Nov-2019 | ||
| JP-2025122076-A | Tubular tissue transformer | Pending | 08-Nov-2019 | A61B17/11 |
Avasa Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Avasa Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Movac | Venture Capital | Minority | ||
| Auckland UniServices | Corporate Venture Capital | Minority | ||
| Booster Innovation Fund | Venture Capital | Minority | ||
| Cure Kids Ventures | Venture Capital | Minority | ||
| New Zealand Growth Capital Partners | Venture Capital | Minority |
Avasa FAQs
-
When was Avasa founded?
Avasa was founded in 2018.
-
Where is Avasa headquartered?
Avasa is headquartered in Auckland, New Zealand.
-
What is the size of Avasa?
Avasa has 2 total employees.
-
What industry is Avasa in?
Avasa’s primary industry is Surgical Devices.
-
Is Avasa a private or public company?
Avasa is a Private company.
-
What is the current valuation of Avasa?
The current valuation of Avasa is .
-
What is Avasa’s current revenue?
The current revenue for Avasa is .
-
How much funding has Avasa raised over time?
Avasa has raised $4.36M.
-
Who are Avasa’s investors?
Movac, Auckland UniServices, Booster Innovation Fund, Cure Kids Ventures, and New Zealand Growth Capital Partners are 5 of 11 investors who have invested in Avasa.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
